These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1978468

  • 1. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
    [Abstract] [Full Text] [Related]

  • 2. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L.
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [Abstract] [Full Text] [Related]

  • 3. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E.
    Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
    [Abstract] [Full Text] [Related]

  • 4. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T, Westerbergh SE, Morrison D.
    Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
    [Abstract] [Full Text] [Related]

  • 8. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R, Soni S, Rastogi SC, Levine S, Plant I, Edwards JG, Mitchell M, Chanas A.
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA, Westenberg HG.
    Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
    [Abstract] [Full Text] [Related]

  • 11. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT.
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [Abstract] [Full Text] [Related]

  • 13. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
    Patris M, Agussol P, Alby JM, Brion S, Burnat G, Castelnau D, Deluermoz S, Dufour H, Ferreri M, Goudemand M.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():78-82. PubMed ID: 1978497
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG, Todd N, Livingston M, Eccleston D, Watt JA, Herrington RN, Tait D, Crocket G, Mitchell MJ, Huitfeldt B.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():136-7. PubMed ID: 1978473
    [Abstract] [Full Text] [Related]

  • 15. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
    Classen W, Laux G.
    Neuropsychobiology; 1989 Sep; 21(3):131-40. PubMed ID: 2575719
    [Abstract] [Full Text] [Related]

  • 16. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J, Holm AC.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():158-63. PubMed ID: 1978477
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL, Appelberg B, Kuoppasalmi K, Katila H, Rimón R.
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [Abstract] [Full Text] [Related]

  • 18. Cognitive disturbances in neuroleptic therapy.
    Strauss WH, Klieser E.
    Acta Psychiatr Scand Suppl; 1990 Dec; 358():56-7. PubMed ID: 1978491
    [Abstract] [Full Text] [Related]

  • 19. Remoxipride in schizophrenia. A preliminary report.
    den Boer JA, Verhoeven WM, Westenberg HG.
    Acta Psychiatr Scand; 1986 Oct; 74(4):409-14. PubMed ID: 2880457
    [Abstract] [Full Text] [Related]

  • 20. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
    Morrison D, Englund A, Lawrie V, Lewander T, Schlachet A, Westerbergh SE.
    Acta Psychiatr Scand Suppl; 1990 Oct; 358():164-9. PubMed ID: 1978478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.